Eton Pharmaceuticals, Inc. · NASDAQ:ETON

Krempa David sold 4,166 Eton Pharmaceuticals, Inc. shares (Form 4)

Traded Oct 2 to Oct 6, 2026 · Filed Oct 6, 2026

From Oct 2 to Oct 6, 2026, Krempa David (Chief Business Officer) sold 4,166 Eton Pharmaceuticals, Inc. shares at US$55.07 for US$229K, leaving 43,381 shares. Filed Oct 6, 2026 (Form 4).

Sold
4,166 shares
Price
US$55.07
Value
US$229K
Holding after
43,381 shares
Trading plan
No
Role
Chief Business Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 2, 2026Common StockOption exercise10,52247,547Direct
Oct 6, 2026Common StockSale4,166US$55.0743,381Direct

Source

View original at SEC

Related